Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA clears Accuray's entire body CyberKnife radiosurgery:

This article was originally published in Clinica

Executive Summary

Accuray has received US FDA 510(k) clearance to market its robotic system for providing noninvasive radiosurgical ablation therapy for lesions anywhere in the body where radiation treatment is indicated. The CyberKnife with Dynamic Tracking Software is a stereotactic radiosurgery system that integrates robotics with image-guidance technology to destroy small tumours with large doses of accurately targeted radiation. The CyberKnife was previously cleared by the FDA in 1999 for use in the head and neck above the cervico-thoracic junction, says the Sunnyvale, California firm.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT073812

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel